🔊CEOInterviews

Tim Czartoski on technology

From The Usefulness of Technology – A Perspective from Industry by Tim Czartoski · · Anterior Hip Foundation

“Technology is everywhere and everything that we touch, but it's connected and the connected part of it makes a big difference in terms of data collection and what we do with that data. It's not just data; it's what we do with and interpret the insights we generate.”

Tim Czartoski
President of U.S. Surgical and Global Product & Enabling Technologies, ENOVIS CORP
technologydata analyticsconnected devices

On , Tim Czartoski, President of U.S. Surgical and Global Product & Enabling Technologies at ENOVIS CORP, spoke about technology during The Usefulness of Technology – A Perspective from Industry by Tim Czartoski on Anterior Hip Foundation.

The Usefulness of Technology – A Perspective from Industry by Tim Czartoski
Watch on YouTube
The Usefulness of Technology – A Perspective from Industry by Tim Czartoski
Anterior Hip Foundation
Watch on YouTube
A talk by Tim Czartoski of DePuy Synthes entitled The Usefulness of Technology – A Perspective from Industry at the 2022 AHF ...
Tim Czartoski

About Tim Czartoski

President of U.S. Surgical and Global Product & Enabling Technologies · ENOVIS CORP

Tim Czartoski, president of U.S. Surgical and Global Product & Enabling Technologies at Enovis, delivered a talk in September 2022 at the AHF conference titled "The Usefulness of Technology – A Perspective from Industry." During the presentation, he discussed how companies evaluate and invest in medical technology. He noted that the price of technology tends to decrease over time, using the example of a Toyota Camry whose cost remained around $21,000 over 20 years despite significant digital upgrades. Czartoski stated that traditional valuation models like discounted cash flow are inadequate for technology because indirect returns are difficult to predict, and companies must instead place bets on which technologies will shift the "s-curve" of innovation. Czartoski also addressed challenges related to data in healthcare. He said that 90 percent of big data projects fail due to a lack of clear definitions for data needs and use cases. He emphasized the importance of data integrity, security, and patient ownership of data, and noted that regulatory pathways through the FDA remain a challenge. He described Johnson & Johnson's approach to innovation as relying on an open platform that includes global innovation centers

Profile compiled from Tim Czartoski's verified public interviews and appearances. See all quotes & transcripts →

More from Tim Czartoski ENOVIS CORP (ENOV) Full Transcript Explore All Executives